Neurovascular disorders or diseases refers to abnormality associated within blood vessels supplying blood to the brain and spine. This includes narrowing of arteries, which reduces blood flow to the brain and increases the risk of stroke (particularly “ischemic” stroke), and weakening of arteries, which may create brain aneurysms and increases the risk of intracranial bleeding (or “hemorrhagic” stroke).
Neurovascular intervention deals with diagnosis, treatment and prevention of vascular disorders affecting central nervous system (brain and spine). Neurovascular intervention mainly addresses two major disease areas, which are broadly defined as hemorrhagic stroke and ischemic stroke.
Growth of global neurovascular intervention market is driven by rising prevalence of cerebrovascular diseases, higher incidences of neurological disorders, favourable reimbursement policies and expanding healthcare infrastructure. However, the market faces several challenges such as high treatment cost, multiple product recalls, dearth of skilled neurosurgeons and social stigma. The market is characterized by leading trends such growth in mergers & acquisition activities, Technological advancement and use of minimally invasive techniques.
Global Neurovascular Intervention Market - Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System Market Outlook 2022 provides in-depth analysis of the current scenario, detailed market outlook of the global neurovascular intervention market with coverage on major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System. Future forecasts of neurovascular intervention overall and across various sub-segments till 2022 is provided in the report. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major international industry players operating in the global neurovascular intervention market include Johnson & Johnson - DePuy Synthes, Stryker Corporation, Medtronic Plc., Penumbra Inc., Terumo Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global neurovascular intervention market.
Minimally invasive procedures and emergence of new techniques such as MicroNet Mesh for Embolic Prevention and Flow Diversion has been latest trends in the global neurovascular intervention market. The report Global Neurovascular Intervention Market - Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System Market Outlook 2022 provides an in-depth analysis of neurovascular intervention market overall as well as major market segments such as Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm and Carotid Artery Stenting (CAS) System. Market outlook for overall neurovascular intervention market as well as aforementioned sub-segments has been provided for the period 2017-2022.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global neurovascular intervention market.
The report has been segmented as following:
- Cerebral Thrombectomy Devices
- Flow Diverter for Aneurysm
- Carotid Artery Stenting (CAS) System
- The US
- Johnson & Johnson DePuy Synthes
- Stryker Corporation
- Medtronic Plc.
- Penumbra Inc.
- Terumo Corporation
1. Executive Summary
2. Research Methodology
3. Neurovascular Market
3.1.2 Neurovascular Devices
3.2 Market Analysis
3.2.1 Market Sizing (Actual & Forecasted)
3.2.2 Market Share by Region
3.2.3 Market Share by Therapeutic Application
3.2.4 Market Share by Technique
4. Global Neurovascular Market Segmentation
4.1 Cerebral Thrombectomy Devices
4.1.2 Market Sizing (Actual & Forecasted)
4.1.3 Market Share by Region
4.2 Flow Diverter for Aneurysm
4.2.2 Market Sizing
4.2.3 Market Share
4.3 Carotid Artery Stenting (CAS) System
4.3.2 Market Sizing
4.3.3 Market Share by Region
5. The US Neurovascular Intervention Market
5.1 Market Analysis
5.1.1 Market Sizing (Actual & Forecasted)
5.1.2 Market Share by Segment
5.2 Market Segmentation
5.2.1 Cerebral Thrombectomy Devices Market Sizing (Actual & Forecasted)
5.2.2 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
5.2.3 Carotid Artery Stenting (CAS) Systems Devices Market Sizing (Actual & Forecasted)
6. Global Neurovascular Market Dynamics
6.1 Industry Trends & Developments
6.1.1 Mergers & Acquisitions
6.1.2 Technological Advancement
6.1.3 Minimally Invasive Techniques
6.2 Growth Drivers
6.2.1 Rising Prevalence of Cerebrovascular disease
6.2.2 Higher Incidences of Neurological Disorders
6.2.3 Favorable Reimbursement Policies
6.2.4 Expanding Healthcare Infrastructure
6.3.1 High Cost of Treatment
6.3.2 Multiple Product Recalls
6.3.3 Dearth of Skilled Neurosurgeons
6.3.4 Social Stigma
7. Competitive Landscape
7.2 The US
8. Company Profiles
8.1 Johnson & Johnson - DePuy Synthes
8.2 Stryker Corporation
8.3 Medtronic Plc.
8.4 Penumbra Inc.
8.5 Terumo Corporation